Aim: To determine the mortality in a cohort of very young injecting drug users (IDUs), and the factors associated with it. Design: A database linkage prospective (follow-up) cohort study. Setting: A convenience sample of clients of 2 low-threshold facilities, 1 drug treatment clinic, and one special facility for children with severe behavioural disorders, who were all younger than 19 and older than 15, was interviewed one or more times in 1996-8 and asked to agree with their being interviewed again after 10 or more years.
INTRODUCTION
The mortality of some illegal drugs users, and IDUs in particular, is known to be extremely high when compared with the general population -albeit differing from one group of drug users to another depending on factors such as sociodemography, the availability of specialised services, and others -in most of the "Western world".
A major review that summarised the results of studies on the overall mortality of drug users performed in the European Union Member States in the period from the 1960s through to 2007 found a low level of mutual comparability both in terms of the methodologies used and the definitions of the target population (1); however, most of the overall mortality studies studied heroin injectors and almost all of them recruited exclusively "problem drug users" as defined by the European Monitoring Centre for Drug Addiction (EMCDDA), that is, long-term and regular and/ or injecting users of opioids and/or cocaine and/or amphetaminetype drugs (2) . The "approximate, modal or typical results" were: crude mortality rate 1-2% annually, with injectors' modus at 3%; overdoses accounted for 20-60% of the overall mortality of drug users in the studies reviewed, and the proportion of 40% seemed to be an "average" figure for fatal overdoses as causes of death in the studies reviewed. Major differences in overall mortality were found between "high-HIV" and "low-HIV" EU countries; in Italy, Spain, Scotland and in some German studies, HIV-related deaths accounted for as much as approximately 40% of the mortality of drug users. The majority of the studies reviewed (1) reported standardised mortality ratios (SMR) to be between 10 and 15.
According to a recent review paper with a wider geographic scope than the previous one, the crude mortality rate (CMR) of opiate users is estimated to be 2.09 deaths per 100 person-years (PY) (95% CI; 1.93, 2.26) globally, and the standardised mortality ratio (SMR) is estimated to be as high as 14.26 (95% CI: 12.82, 16.50), with males having a higher CMR and lower SMR than females (3). For users of stimulants, fewer studies of sufficient quality are available; the recent review reports the CMRs as ranging from 0 in Australia to 2.95 in Thailand; the SMRs were not found for stimulant users except a 2007 Czech study (4) (5) (6) . A new Swedish study of 561 patients admitted to detoxification in 1970-78 found the SMR to be 5.94, with a large SMR difference in subjects aged 20-44 (SMR=18) and 45+ (SMR=5). As for predictors of death, in an Australian study of the mortality of users of opiates, the only statistically significant predictor was a prior history of opiate overdoses (7) ; in other studies, there are no statistically significant predictors found, and some of the suspected predictors can be rather seen as "proxies" of "chaotic lives" -typically, history of a frequent imprisonment, or the reported use of "drug cocktails" in one injection (for the concept of the "chaotic live proxies", see, e.g., 8).
MATERIAL AND METHODS
In 1995-1998, Csemy ran a set of surveys and field studies in different groups of adolescents and young adults using and not using drugs; the studies were parts of a broader project seeking predictors of several types of risky behaviours (9) . One of the groups studied consisted of 183 injecting drug users younger than nineteen and older than fifteen years of age. All the members of this group were interviewed thoroughly, answering questions on their social and demographic status, their drug career, and a set of other questions. Field researchers asked every study participant to agree with their further participation in a follow-up study that would include further interviews "after 10 or more years after recruitment" within the process of informing them about the study and their signing an informed consent. Of the 183 participants approached, 151 agreed and were included in the reported follow-up study. The main characteristics of our sample are shown in Table 1 .
In 2010, we conducted a database linkage study in order to examine the life status of the 151 participants who agreed to be followed up. The IDs used for linkage of the database of participants in the 1990s study with the general mortality register was their personal ID enciphered by the control sum-based one-way ciphering program "EpiCrypt", which is approved for use in similar studies by the Czech Office for Personal Data Protection as unbreakable by any other means than a brute force attack, which is seen by this national data protection authority as technically unreasonable (10) . We used the STATA 11 statistical package for data management and analysis. 
RESULTS
We followed our cohort for 1,659.7 person-years (M 676.3 PY, F 983.4 PY), of which the heroin users were followed for 692.0 PY, users of pervitin (methamphetamine) for 863.2 PY, and users of other drugs for 104.6 PY. After linking the databases, we identified 8 cases of death in our cohort in the period between their recruitment and 31st December 2008. After a careful verification of the death causes and in cases where the ICD-10 coding (11) in the general mortality database was absent or ambivalent, we identified the deaths, their causes and principal characteristics of the deceased as summarised in Table 2 .
All of the cases of death were found in males; in females, no death was registered during the follow-up period; this represents a level of mortality "lower" than expected in the standardised female population. All the cases of death were "unnatural" -that is, caused by external causes. Four deaths (numbers 2-5 in Table  2 ; 50% of all those identified) were caused by a lethal overdose of an illegal drug; another fatal overdose (No. 1 in Table 2 ) was a suicide committed with cyanide and yet another lethal overdose (No. 8 in Table 2 ) was caused by (legal) alcohol. The remaining two deaths were (violent) accidents, with one of the two cases (No. 6 in Table 2 ) representing another suspected suicide (hit by a train).
Our findings represent high crude mortality rates of 1.48% per year for males, and 0.48% per year for the whole cohort. Given the extremely young age of the cohort members, this translates into a very high specific mortality ratio for males (SMR=14.4) with the peak at the age of 15-20 (SMR=60.1), declining to SMR=8.2 at the age of 25-30. The highest SMR was found in the male heroin injectors aged 15-19 (point estimate 127.8); the peak of mortality for methamphetamine (pervitin) occurred somewhat later, in the 20-24 age group (for details, see Table 3 ; for survival estimate of males in the cohort and the cumulative hazard estimates for both genders see Figures 1 and 2, respectively) .
We attempted to find "predictors" of death, using as independent variables the sociodemographic data, variables related to drug career, data covering mental health and family anamnesis, and SMR estimates the excess of mortality rate of the cohort that was followed as compared with a standardised population, i.e. with the mortality of the "average" population of the same country with a gender and age structure identical to the cohort that was followed. variables related to contacts with helping institutions, all of which were gathered by Csemy's study in the 1990s (9) . Altogether, we performed a set of statistical tests using 52 independent variables; however, in this phase of the study, we found no statistically significant predictors of death in our cohort except gender (p<0.001). Similarly, we did not find any statistically significant proportional hazard model.
Date of the interview

DISCUSSION
The recruitment took part in the declining phase of the first (and, so far, last) heroin epidemic, which hit the Czech Republic in the early 1990s and was particularly pronounced and visible in the capital city, Prague, and in Western Bohemia (for details, see, e.g., [12] [13] [14] [15] . Early after the fall of communism, problem drug use was less concentrated in the marginalised and socially disadvantaged strata of society than in countries with a longer drug history, and the Czech Republic nowadays: of the 151 members of our cohort, only eleven people were homeless/living on the street, and 100 of the study participants lived with their parents at the time of recruitment, when they were using the service(s) specified in Table 1 . Despite the relatively low number of members in our cohort, which represents its main limitation, the relatively long follow-up period makes our study unique since to the best of our knowledge it is the only prospective cohort study covering quite different periods of the Czech "drug history".
Most of the deaths occurred at a very young age and relatively shortly after recruitment; as it is obvious in the cumulative hazard function, after a "high-risk" period that is as long as 3 years after recruitment, a long plateau followed, with two deaths at the end of the follow-up period (see Fig. 2 ). Except one suicidal poisoning, Fig. 1 all these early deaths were caused by drug overdoses -despite the fact that our cohort includes larger number of methamphetamine injectors, three fatal overdoses were caused by heroin, and only one by methamphetamine, which is probably related to the different levels of toxicity of the two substances (16) . Our findings are also in accord with the results of other studies of mortality among drug users, which show higher potential for overdoses in opiates than in stimulants, and point out the extremely elevated risk of fatal overdoses (and deaths in general) in young male injectors in the first years of their injecting careers (3, 4, (17) (18) (19) .
The comparison of our results with much larger cohorts from Czech retrospective studies of the mortality of medical in-patients and/or patients of opiate substitution treatment (OST) (5, 20) shows that the survival probabilities in our study are substantially lower (Fig. 1 ) than those found in the two extensive retrospective studies; in Table 4 , we show the survival probabilities found in the larger and more recent retrospective study (20) , where the cohort was recruited from patients of in-patient facilities and OST patients in 1997-2007. This difference in survival probabilities may be explained by the very young age in our cohort, and by the fact that most of the cohort participants were recruited in low-threshold facilities -that is, in facilities providing services to those users of illegal drugs who are not able and/or willing to cease their drug use (usually high-risk injecting drug use) at that moment; by definition, this is the second most vulnerable population of drug users (next to non-institutionalised problem drug users (see, e.g., 21, 22) ).
In our study, all the deaths were violent and as such, preventable. Since naïve, young and relatively inexperienced drug users are those most at risk not only in terms of deaths, but also in terms of other health hazards such as blood-borne infections related to drug use (23, 24) . Thus, our findings further stress the public health's need to develop interventions targeting this group of new injectors in order to protect their lives and health in general, such as active support for switching from injecting to other patterns of drug use with similar perceived drug effects (25) , or the safe injecting rooms/facilities that are increasingly being introduced in the cities of the EU, Australia and the Americas (26) .
CONCLUSION
The mortality in the male part of the cohort of young injecting drug users recruited in 1996-1998 in Prague was excessively high in the first three years after recruitment and all cases of death were caused by external causes exclusively. The mortality in females was zero, i.e. lower than in the general population of the same age group, and substantially lower than in other studies that included female drug users both abroad and in the Czech Republic.
Our findings suggest a need to develop targeted prevention strategy aimed at danger of overdoses and other unnatural causes of death in very young male drug injectors, and in new, "naïve" IDUs. Introduction and support for innovative harm reduction measures specific to these overlapping target groups should be considered in the Czech Republic.
